2,376
Views
48
CrossRef citations to date
0
Altmetric
Original Articles

A comparative study of short-term efficacy and safety for thyroid micropapillary carcinoma patients after microwave ablation or surgery

, , , , &
Pages 639-645 | Received 13 Feb 2019, Accepted 28 May 2019, Published online: 27 Jun 2019

References

  • Jegerlehner S, Bulliard JL, Aujesky D, et al. Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. PloS One. 2017;12:e0179387.
  • Jung KW, Won YJ, Oh CM, et al. Prediction of cancer incidence and mortality in Korea, 2017. Cancer Res Treat. 2017;49:306–312.
  • Munim H, Deen KMB, Amanda J, Janis C. Cancers of the thyroid: overview and statistics in the United States and Oklahoma. J Okla State Med Assoc. 2016;109:7–8.
  • Gartland RM, Lubitz CC. Impact of extent of surgery on tumor recurrence and survival for papillary thyroid cancer patients. Ann Surg Oncol. 2018;25:2520–2525.
  • Adam MA, Pura J, Goffredo P, et al. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab. 2015;100:115–121.
  • Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140:317–322.
  • Yeh MW, Bauer AJ, Bernet VA, et al. American thyroid association statement on preoperative imaging for thyroid cancer surgery. Thyroid. 2015;25:3–14.
  • Dobrinja C, Pastoricchio M, Troian M, et al. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated? Int J Surg. 2017;41 Suppl 1:S34–S39.
  • McLeod DSA, Sawka AM, Cooper DS. Controversies in primary treatment of low-risk papillary thyroid cancer. Lancet. 2013;381:1046–1057.
  • Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19:632–655.
  • Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21:S192–S203.
  • Carrafiello G, Lagana D, Mangini M, et al. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg. 2008; 6:S65–S9.
  • Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: Initial experience. Int J Hyperthermia. 2014;30:150–157.
  • Yue W, Chen L, Wang S, et al. Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: a prospective study. Int J Hyperthermia. 2015;31:403–408.
  • Li J, Liu Y, Liu J, et al. Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma. Int J Hyperthermia. 2018;34:653–659.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
  • Khanna R, Sharma AD, Khanna S, et al. Usefulness of ultrasonography for the evaluation of cervical lymphadenopathy. World J Surg Oncol. 2011;9:29.
  • Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26:1581–1587.
  • Morelli F, Sacrini A, Pompili G, et al. Microwave ablation for thyroid nodules: a new string to the bow for percutaneous treatments?. Gland Surg. 2016;5:553–558.
  • Oluic B, Paunovic I, Loncar Z, et al. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience. BMC Cancer. 2017;17:371.
  • Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388:2783–2795.
  • Papini E, Bizzarri G, Pacella CM. Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obesity. 2008;15:434–439.
  • Zhou W, Jiang S, Zhan W, et al. Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results. Eur Radiol. 2017;27:2934–2940.
  • Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011;21:917–920.
  • Yu J, Liang P, Yu X, et al. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2011;79:124–130.
  • Teng DK, Li HQ, Sui GQ, et al. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine. 2019;64:109–117.
  • Korkusuz Y, Groner D, Raczynski N, et al. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods? Eur Radiol. 2018;28:929–935.
  • Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20:11–22.
  • Liu Z, Zeng W, Liu C, et al. Diagnostic accuracy of ultrasonographic features for lymph node metastasis in papillary thyroid microcarcinoma: a single-center retrospective study. World J Surg Oncol. 2017;15:32.
  • Takaki H, Cornelis F, Kako Y, et al. Thermal ablation and immunomodulation: from preclinical experiments to clinical trials. Diagn Interv Imaging. 2017;98:651–659.
  • Rao P, Escudier B, de Baere T. Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Intervent Radiol. 2011;34:424–430.
  • Kim H, Park BK, Kim CK. Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma. Korean J Radiol. 2008;9:470–472.
  • Teng D, Ding L, Wang Y, et al. Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study. Endocrine. 2018;62:648–654.
  • Zhou W, Chen Y, Zhang L, et al. Percutaneous microwave ablation of metastatic lymph nodes from papillary thyroid carcinoma: preliminary results. World J Surg. 2019;43:1029–1037.
  • Welch HG, Doherty GM. Saving thyroids–overtreatment of small papillary cancers. N Engl J Med. 2018;379:310–312.
  • Kim E, Park JS, Son KR, et al. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid. 2008;18:411–418.
  • Xiang D, Hong Y, Zhang B, et al. Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients: diagnosis value and enhancement patterns of malignant lymph nodes. Eur Radiol. 2014;24:2513–2519.
  • Hall CM, Snyder SK, Maldonado YM, et al. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence. Surgery. 2016;160:1049–1058.
  • Park SY, Jung YS, Ryu CH, et al. Identification of occult tumors by whole-specimen mapping in solitary papillary thyroid carcinoma. Endocrine-Related Cancer. 2015;22:679–686.